Patents by Inventor Stefan Henke

Stefan Henke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070261131
    Abstract: A transgenic plant transformed by a protein kinase stress-related protein (PKSRP) coding nucleic acid, wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic plants. Also provided are isolated PKSRP, and isolated nucleic acid coding PKSRP, and vectors and host cells containing the latter. Further provided are methods of producing transgenic plants expressing PKSRP, and methods of identifying novel PKSRP and methods of modifying the expression of PKSRP in plants.
    Type: Application
    Filed: January 10, 2007
    Publication date: November 8, 2007
    Inventors: Oswaldo da Costa e Silva, Manabu Ishitani, Stefan Henkes, Nocha van Thielen, Ruoying Chen
  • Publication number: 20070236017
    Abstract: The invention relates to a fitting for connecting lengths of pipe or tube by compression, having a substantially cylindrical internal contour. The fitting has at least one ridge which is configured in a radially outward direction and in which a sealing element is provided. The fitting is slidable onto the lengths of pipe or tube, the internal contour of the fitting having a region of non-circular cross-section at least one end. The invention also relates to a connecting arrangement for connecting lengths of pipe or tube by compression, comprising at least one length of pipe or tube and a fitting plus a sealing element which is arranged between the two latter in a ridge in the fitting. The internal contour of the fitting is partly of a non-round form and at least one axial gap which extends over the entire connecting region is formed between the length of pipe or tube and the internal contour of the fitting in the uncompressed state.
    Type: Application
    Filed: June 24, 2005
    Publication date: October 11, 2007
    Applicant: Yorkshire Fittings Ltd.
    Inventor: Stefan Henke
  • Patent number: 7223903
    Abstract: A transgenic plant transformed by a protein kinase stress-related protein (PKSRP) coding nucleic acid, wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic plants. Also provided are isolated PKSRP, and isolated nucleic acid coding PKSRP, and vectors and host cells containing the latter. Further provided are methods of producing transgenic plants expressing PKSRP, and methods of identifying novel PKSRP and methods of modifying the expression of PKSRP in plants.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: May 29, 2007
    Inventors: Oswaldo da Costa e Silva, Manabu Ishitani, Stefan Henkes, Nocha van Thielen, Ruoying Chen
  • Patent number: 7220896
    Abstract: A transgenic plant transformed by a pyrophosphatase stress-related protein (PPSRP) coding nucleic acid, wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic plants. Also provided are isolated PPSRP, and isolated nucleic acid coding PPSRP, and vectors and host cells containing the latter. Further provided are methods of producing transgenic plants expressing PPSRP, methods of identifying novel PPSRP, and methods of modifying the expression of PPSRP in plants.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: May 22, 2007
    Assignee: BASF Plant Science GmbH
    Inventors: Stefan Henkes, Ruoying Chen, Nocha van Thielen, Oswaldo da Costa e Silva
  • Publication number: 20070077296
    Abstract: The invention relates to novel solid formulations comprising as pharmaceutically active compound meloxicam and to processes for producing such solid formulations. The invention furthermore relates to a method for manufacturing a medicament for the prevention and/or treatment of pain, inflammation, fever, acute mastitis, diarrhoea, locomotive disorders, lameness, osteoarthritis, problems of mobility or respiratory complaints, wherein the solid formulations according to the invention are used.
    Type: Application
    Filed: September 19, 2006
    Publication date: April 5, 2007
    Inventors: Martin Folger, Stefan Henke, Jens Schmalz
  • Publication number: 20060079516
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: November 30, 2005
    Publication date: April 13, 2006
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin Folger, Klaus Daneck, Axel Prox
  • Publication number: 20050277634
    Abstract: A liquid composition comprising: meloxicam, penethamate hydroiodide, and at least one solvent.
    Type: Application
    Filed: May 18, 2005
    Publication date: December 15, 2005
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Dietrich Janott, Stefan Henke, Martin Folger, Peter Riechel, Bernhard Hassel
  • Publication number: 20050266073
    Abstract: The invention relates to rapidly dissolving granules obtainable by preparing an aqueous granulating liquid containing at least one binder; spraying the granulating liquid obtained in step (a) in a fluidized bed by the counter-flow method at a constant air supply temperature on to a carrier containing at least one carbohydrate, wherein bromhexin/bromhexinhydrochloride and citric acid are used independently of one another in the granulating liquid and/or carrier. For the first time the teaching according to the invention provides a water soluble granulated preparation which contains bromhexin/bromhexinhydrochloride as active substance. These granules according to the invention are water soluble in spite of the fact that bromhexin/bromhexinhydrochloride per se is almost insoluble in water, i.e., the granules are fully dissolved in water within a few minutes and release the active substance in its entirety.
    Type: Application
    Filed: May 12, 2005
    Publication date: December 1, 2005
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin Folger, Stefan Henke, Jens Schmalz
  • Publication number: 20050203097
    Abstract: The invention relates to novel solid formulations comprising as pharmaceutically active compound pimobendan and to processes for producing such solid formulations. The invention furthermore relates to a method for manufacturing a medicament for the prevention and/or treatment of congestive heart failure, wherein the solid formulations according to the invention are used.
    Type: Application
    Filed: March 4, 2005
    Publication date: September 15, 2005
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin Folger, Bernhard Hassel, Stefan Henke, Jens Schmalz
  • Patent number: 6932789
    Abstract: Needle-less injectors for liquids are known in many different forms which are adapted to different conditions of use. The needle-less injector according to the invention is in the form of a hand-held unit. It includes a locking stressing mechanism, an energy-storing spring (36), a hollow plunger (37) displaceable in a cylinder (38) and a nozzle (39). At its one end, the hollow plunger is provided with a valve body (42). The supply container (44) for the liquid is arranged within the housing. When the locking stressing mechanism is stressed by rotation of the two housing portions (31, 32) relative to each other the hollow plunger (37) is drawn out of the cylinder (38); at the same time the amount of liquid required for an injection is conveyed out of the supply container (44) through the plunger into the pump chamber (43). After the locking stressing mechanism is triggered the amount of liquid is expelled from the pump chamber through the nozzle.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: August 23, 2005
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Bernd Zierenberg, Ralph Christian Reimholz, Knut Elbers, Stefan Henke, Joachim Eicher, Johannes Geser
  • Publication number: 20040219525
    Abstract: The present invention provides novel polynucleotides encoding plant prenyl protease polypeptides, fragments and homologs thereof. Also provided are vectors, host calls, antibodies, and recombinant methods for producing said polypeptides. The invention further provides novel polynucleotide, encoding plant promoters, polypeptides, fragments and homologs thereof. The invention further relates to methods of applying these novel plant polypeptides to the identification, prevention, and/or conferment of resistance to various plant diseases and/or disorders, particularly drought resistence.
    Type: Application
    Filed: August 27, 2003
    Publication date: November 4, 2004
    Inventors: Heiko Haertel, Volker Mittendorf, Stefan Henkes, Oswaldo da Costa e Silva
  • Publication number: 20040180092
    Abstract: Water soluble meloxicam granules comprising:
    Type: Application
    Filed: October 27, 2003
    Publication date: September 16, 2004
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Martin Andreas Folger, Jens Schmalz, Diana Christine Keilhofer, Hans-Juergen Kroff, Nina Herz
  • Publication number: 20040055032
    Abstract: A transgenic plant transformed by a pyrophosphatase stress-related protein (PPSRP) coding nucleic acid, wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic plants. Also provided are isolated PPSRP, and isolated nucleic acid coding PPSRP, and vectors and host cells containing the latter. Further provided are methods of producing transgenic plants expressing PPSRP, methods of identifying novel PPSRP, and methods of modifying the expression of PPSRP in plants.
    Type: Application
    Filed: November 18, 2002
    Publication date: March 18, 2004
    Inventors: Stefan Henkes, Ryouing Chen, Nocha van Thielen, Oswaldo da Costa e Silva
  • Patent number: 6689092
    Abstract: Needle-less injectors for liquids are known in many different forms which are adapted to different conditions of use. The needle-less injector according to the invention is in the form of a hand-held unit. It includes a locking stressing mechanism, an energy-storing spring (36), a hollow plunger (37) displaceable in a cylinder (38) and a nozzle (39). At its one end, the hollow plunger is provided with a valve body (42). The supply container (44) for the liquid is arranged within the housing. When the locking stressing mechanism is stressed by rotation of the two housing portions (31, 32) relative to each other the hollow plunger (37) is drawn out of the cylinder (38); at the same time the amount of liquid required for an injection is conveyed out of the supply container (44) through the plunger into the pump chamber (43). After the locking stressing mechanism is triggered the amount of liquid is expelled from the pump chamber through the nozzle.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: February 10, 2004
    Assignee: Boehringer International GmbH
    Inventors: Bernd Zierenberg, Ralph Christian Reimholz, Knut Elbers, Stefan Henke, Joachim Eicher, Johannes Geser
  • Publication number: 20040015126
    Abstract: Needle-less injectors for liquids are known in many different forms which are adapted to different conditions of use. The needle-less injector according to the invention is in the form of a hand-held unit. It includes a locking stressing mechanism, an energy-storing spring (36), a hollow plunger (37) displaceable in a cylinder (38) and a nozzle (39). At its one end, the hollow plunger is provided with a valve body (42). The supply container (44) for the liquid is arranged within the housing. When the locking stressing mechanism is stressed by rotation of the two housing portions (31, 32) relative to each other the hollow plunger (37) is drawn out of the cylinder (38); at the same time the amount of liquid required for an injection is conveyed out of the supply container (44) through the plunger into the pump chamber (43). After the locking stressing mechanism is triggered the amount of liquid is expelled from the pump chamber through the nozzle.
    Type: Application
    Filed: July 14, 2003
    Publication date: January 22, 2004
    Inventors: Bernd Zierenberg, Ralph Christian Reimholz, Knut Elbers, Stefan Henke, Joachim Eicher, Johannes Geser
  • Publication number: 20030217392
    Abstract: A transgenic plant transformed by a protein kinase stress-related protein (PKSRP) coding nucleic acid, wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic plants. Also provided are isolated PKSRP, and isolated nucleic acid coding PKSRP, and vectors and host cells containing the latter. Further provided are methods of producing transgenic plants expressing PKSRP, and methods of identifying novel PKSRP and methods of modifying the expression of PKSRP in plants.
    Type: Application
    Filed: November 18, 2002
    Publication date: November 20, 2003
    Inventors: Oswaldo da Costa e Silva, Manabu Ishitani, Stefan Henkes, Nocha van Thielen, Ruoying Chen
  • Publication number: 20030140380
    Abstract: A transgenic plant transformed with an Amine Oxidase Stress-Related Protein (AOXSRP) coding nucleic acid, wherein expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant. Also provided are agricultural products, including seeds, produced by the transgenic plants. Also provided are isolated AOXSRPs, and isolated nucleic acids encoding AOXSRPs, and vectors and host cells containing the latter.
    Type: Application
    Filed: November 12, 2002
    Publication date: July 24, 2003
    Inventors: Stefan Henkes, Ruoying Chen, Oswaldo da Costa e Silva, Nocha Van Thielen
  • Publication number: 20030119825
    Abstract: Aqueous cyclodextrin-free solution of meloxicam suitable for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being from 35 to 100 mg/ml. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: December 9, 2002
    Publication date: June 26, 2003
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin Andreas Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • Publication number: 20020058908
    Abstract: Needle-less injectors for liquids are known in many different forms which are adapted to different conditions of use.
    Type: Application
    Filed: March 2, 2001
    Publication date: May 16, 2002
    Inventors: Bernd Zierenberg, Ralph Christian Reimholz, Knut Elbers, Stefan Henke, Joachim Eicher, Johannes Geser
  • Publication number: 20020035107
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: May 18, 2001
    Publication date: March 21, 2002
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox